In 2012, a study was published to compare metformin with insulin as treatment of GDM and, furthermore, to characterize metformin-treated patients needing additional insulin to achieve prespecified glucose targets (99 mg/dl fasting glucose and 140 mg/dl 1 h after meal) (22). Here, INS is linked to gestational diabetes.